ATRC - AtriCure Inc logo

AtriCure Inc

ATRC

AtriCure develops, manufactures, and sells devices for surgical ablation of cardiac tissue and intercostal nerves. Its product portfolio includes systems for treating cardiac arrhythmias and pain management, serving medical centers globally.

โš•๏ธ Healthcare NASDAQ Listed 2005 $ USD
$1,000 invested 20 years ago โ†’$8,499today

Score Overview

1 Year
Score
Net Growth192.17%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth6.57%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score5.6
Net Growth-78.98%
Net Trend60%
Net Income Consistencyโ€”
Rev Growth107.64%
Rev TrendEvery year
Revenue Consistencyโ€”
10 Years
Score
Net Growth131.65%
Net Trend60%
Net Income Consistency
Rev Growth267.24%
Rev Trend90%
Revenue Consistency
20 Years
Score4.8
Net Growth176.92%
Net Trend45%
Net Income Consistency
Rev Growth14x
Rev Trend90%
Revenue Consistency
All Time
Score
Net Growth183.20%
Net Trend43%
Net Income Consistency
Rev Growth18x
Rev Trend90%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where AtriCure Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 20 years of fundamentals. ATRC does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-09-29
$ 58.05โ€”
1 Year2025-09-29
$ 34.8766.48%
5 Years2021-09-29
$ 69.28-16.21%
10 Years2016-09-29
$ 15.36277.93%
20 Years2006-09-29
$ 6.838x
All Time2005-08-05
$ 14.08312.29%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 569M$ 10M$ 167M
2025$ 534M-$ 11M$ 167M
2024$ 465M-$ 44M$ 122M
2023$ 399M-$ 30M$ 137M
2022$ 330M-$ 46M$ 121M
2021$ 274M$ 50M$ 119M
2020$ 206M-$ 48M$ 244M
2019$ 230M-$ 35M$ 81M
2018$ 201M-$ 21M$ 124M
2017$ 174M-$ 26M$ 34M
2016$ 155M-$ 33M$ 44M
2015$ 129M-$ 27M$ 34M
2014$ 107M-$ 16M$ 59M
2013$ 81M-$ 11M$ 26M
2012$ 70M-$ 7M$ 12M
2011$ 64M-$ 5M$ 14M
2010$ 59M-$ 3M$ 12M
2009$ 54M-$ 16M$ 15M
2008$ 55M-$ 10M$ 11M
2007$ 48M-$ 11M$ 20M
2006$ 38M-$ 13M$ 19M
IPO2005$ 30M-$ 12M$ 33M
ATRC - AtriCure Inc logo

AtriCure Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 206M to $ 534M and net income went from -$ 48M to -$ 11M. Revenue increased in every one of those 5 years; net income in 3.

Between 2015 and 2025, revenue grew from $ 129M to $ 534M and net income went from -$ 27M to -$ 11M. Revenue increased in 9 of those 10 years; net income in 6.

AtriCure Inc currently holds a 20-year HDB Score of 4.8 out of 10. How the HDB Score is calculated.

Membership

Explore ATRC with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 3,814 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies